ISRCF:OTC-iShares V Public Limited Company - iShares S&P 500 Information Technology Sector UCITS ETF (USD)

ETF | Others |

Last Closing

USD 31.32

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

-4.26 (-0.71%)

USD 32.85B
ZKBGF ZKB Gold ETF

+10.00 (+0.44%)

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
EBCRY EBCRY

N/A

USD 3.26B
SSEEF SSgA SPDR ETFs Europe I Public..

N/A

USD 2.95B
IFXAF iShares Asia Trust - iShares F..

N/A

USD 2.94B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B
ISRPF iShares Public Limited Company..

N/A

USD 2.22B

ETFs Containing ISRCF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.22% 91% A- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.22% 91% A- 73% C
Trailing 12 Months  
Capital Gain 37.67% 92% A 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.67% 92% A 77% C+
Trailing 5 Years  
Capital Gain 219.59% 97% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 219.59% 97% N/A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 25.79% N/A N/A 69% C-
Dividend Return 25.79% N/A N/A 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.56% N/A N/A 78% C+
Risk Adjusted Return 100.89% N/A N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike